Allogeneic cellular immunotherapies hold a great promise for cancer treatment owing to
their potential cost-effectiveness, scalability and on-demand availability. However, immune …

Type 1 diabetes mellitus (T1DM) is a growing global health concern that affects
approximately 8.5 million individuals worldwide. T1DM is characterized by an autoimmune …

Biomaterials have gained immense attention for various diseases due to their unique
advantages over chemical drugs regarding cost, ease of production, toxicity, and therapeutic …

Balancing the immune response after solid organ transplantation (SOT) and vascularized
composite allotransplantation (VCA) remains an ongoing clinical challenge. While …

The rise of methicillin-resistant Staphylococcus aureus (MRSA) poses a significant
challenge in clinical settings due to its ability to evade conventional antibiotic treatments …

Highlights•Stressed plants can be transformed into healthy foods.•Oxidative stress plays a
key role in nutraceutical biosynthesis.•Fresh produce, by-products, and waste can be used …

Systemic immunotherapeutics have been a clinical staple in the treatment of cancer,
infectious diseases, organ and cell transplantation, autoimmunity, and allergies. While their …

In the realm of neural regeneration post‐spinal cord injury, hydrogel scaffolds carrying
induced neural stem cells (iNSCs) have demonstrated significant potential. However …

Challenges remain to be solved for the clinical translation of β-cell encapsulation technology
in the treatment of type 1 diabetes (T1D). Successful delivery of β cells urgently needs the …

Background Chronic obstructive pulmonary disease (COPD) currently ranks among the top
three causes of mortality worldwide, presenting as a prevalent and complex respiratory …